A leading global private equity firm was seeking a technical and commercial due diligence check of a target company in the pharmaceutical industry. Specifically, they were looking to assess its development capability, portfolio selection, and manufacturing model, and map out a go-to-market model.

GLG identified multiple experts, all of whom held unique roles within the industry, to offer their diverse perspectives on the industry and the target company.

One of the experts worked closely with the client as an advisor to map out the target’s research and development capability and suggest improvements for formulation development. He reviewed the information provided to him about the target and suggested growth considerations and the way forward. He also made recommendations toward its existing processes relating to manufacturing facilities, R&D capability, and alliances.

The client gained a thorough understanding of the pharmaceutical industry through insights provided by multiple experts while getting a detailed review of the target and its growth prospects from the advisor who collated the findings in a written report.